Related Experiment Video
Updated: Apr 28, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damage
Karin C Nitiss1, John L Nitiss2
1Biomedical Sciences Department, UIC College of Medicine and Department of Biopharmaceutical Sciences, UIC College of Pharmacy, Rockford, Illinois.
Abstract:
Anthracyclines are active clinical agents that have multiple mechanisms of cytotoxicity. Cardiotoxicity by anthracyclines limits the therapeutic potential of these agents, but mechanisms leading to cardiotoxicity remain controversial. Transgenic mice that lack mitochondrial topoisomerase I are hypersensitive to doxorubicin cardiotoxicity, providing support for cardiotoxicity arising from damage of mitochondrial DNA.
Insights
Anthracyclines can cause heart damage, limiting their use. This study suggests that damage to mitochondrial DNA in heart cells contributes to this cardiotoxicity, particularly with doxorubicin.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Anthracyclines are potent chemotherapy drugs with known cytotoxic effects.
- Cardiotoxicity is a significant limitation to anthracycline therapy, and its underlying mechanisms are debated.
- Mitochondrial DNA (mtDNA) is vulnerable to damage and plays a role in cellular health.
Purpose of the Study:
- To investigate the role of mitochondrial DNA damage in anthracycline-induced cardiotoxicity.
- To explore the mechanisms by which doxorubicin exerts its cardiotoxic effects.
Main Methods:
- Utilized transgenic mice lacking functional mitochondrial topoisomerase I.
- Administered doxorubicin to these mice and control groups.
- Assessed cardiotoxicity and mtDNA integrity.
Main Results:
- Mice lacking mitochondrial topoisomerase I exhibited heightened sensitivity to doxorubicin cardiotoxicity.
- This hypersensitivity suggests a critical role for mtDNA integrity in preventing anthracycline-induced heart damage.
Conclusions:
- Damage to mitochondrial DNA is a key mechanism underlying anthracycline cardiotoxicity.
- Targeting mtDNA protection could be a strategy to mitigate doxorubicin's cardiac side effects.
- Further research into mtDNA repair pathways may yield novel cardioprotective interventions.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Mitochondrial Membranes
DNA Damage can Stall the Cell Cycle

